The Homeopathic Pharmacopoeia of the United States

By Mark Land, AAHP president June 1, 2017 The Homeopathic Pharmacopoeia of the United States (HPUS) is the legal basis for marketing homeopathic drug products in the United States and many other countries around the world. The HPUS is officially recognized in the United States Federal Food Drug and Cosmetic Act and other United StatesContinue Reading

2017 Updates in the Homeopathic Pharmacopeia

By Eric L. Foxman, R.Ph., senior scientist, HPCUS June 1, 2017 Before proceeding to review the major areas of updates in the HPUS, two specific items are of timely interest: The Guidelines for Manufacturing Homeopathic Medicines became official on March 31, 2017. The older General Pharmacy section and the Classes of Manufacture are no longerContinue Reading

What is the HPUS and Who Creates It?

By Eric L. Foxman, R.Ph., senior scientist, HPCUS June 1, 2017 Various pharmacopoeias containing homeopathic drugs have been published continually since the 1840s. The Homeopathic Pharmacopoeia of the United States (HPUS) has been in continuous publication for 120 years — since 1897. The HPUS was officially recognized under the U.S. Food Drug and Cosmetic ActContinue Reading

Delivering Key Messages

By Alissa Gould, public relations manager, Boiron USA June 1, 2017 Building on April and May 2017 articles on preparing for important communications and developing key messages, this article will focus on delivering those messages. Now that you have a mental road map of where you want to drive the conversation with a retailer, doctor,Continue Reading

Developing Key Messages

By Alissa Gould, public relations manager, Boiron USA May 1, 2017 Last month (April 2017), I shared an article on being prepared and asking the right questions for media interviews or other situations. This article builds on reviewing communications basics by discussing message development. Whether you are meeting a retailer or health care professional, talkingContinue Reading

Homeopathic Manufacturers Explore Next-Generation Quality Control

MILWAUKIE, Ore., May 4, 2017 — Member companies of the American Association of Homeopathic Pharmacists (AAHP) gathered to learn about promising new technologies recently used by the U.S. Food and Drug Administration (FDA) to analyze homeopathic products. Developments in this area could lead to industry-wide manufacturing advancements as well as improvements to the homeopathic drugsContinue Reading

Disclaimers in Advertising and Labeling: What Do They Do? Who Does What?

By Mark Land, AAHP President May 1, 2017 The FTC has long recognized that marketing claims may include additional explanatory information to prevent the claims from being misleading. This is FTC’s way of saying disclaimers may cure potentially misleading claims in general or, in our case, homeopathic therapeutic claims specifically. Communicating information to consumers inContinue Reading

United States Food and Drug Administration Office of Pharmaceutical Quality

By Mark Land, AAHP President May 1, 2017 The Office of Pharmaceutical Quality (OPQ), created in Jan. 2015, enhances the U.S. Food and Drug Administration Center for Drug Evaluation and Research’s (FDA CDER) Quality Initiative. It creates a drug quality program as robust as the programs the agency already has in place for drug safetyContinue Reading

AAHP Recognized as Voice of Homeopathy on Capitol Hill

MILWAUKIE, Ore., Apr. 10, 2017 — The American Association of Homeopathic Pharmacists’ (AAHP) Legal & Regulatory Committee recently received the 2017 Henry N. Williams Professional Service Award from the National Center for Homeopathy (NCH). Presented on April 1 during the 2017 Joint American Homeopathic Conference, the award honors the committee’s efforts in working with theContinue Reading

Be Prepared: Media Basics for the Non-PR Expert

By Alissa Gould, public relations manager, Boiron USA April 1, 2017 As more people discover the benefits of homeopathic medicines, our industry may become a larger target for skeptics or media struggling to attract an audience through sensationalized stories. This, unfortunately, is a growing pain of success. Whether you work in operations and manufacturing, medicalContinue Reading